CASP3 and osteosarcoma: Our studies demonstrated that luteolin inhibited MG-63 osteosarcoma cell proliferation and induced apoptosis effectively in a dose dependent manner through down-regulating the expression of BCL-2, Caspase-3 and Survivin proteins levels and up-regulating the expression of BAX protein.